⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

VRCA News

Verrica Pharmaceuticals Inc. Common Stock

Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting